Enanta Pharmaceuticals Inc Income Statement

Income Statement Sep2011 Sep2012 Sep2013 Sep2014 Sep2015 Sep2016 Sep2017 Sep2018 Sep2019 Sep2020 Sep2021 Sep2022 Sep2023 Sep2024 Sep2025
Revenue & cost
Revenue 41.88M41.71M32.05M47.74M160.88M88.27M102.81M206.62M205.20M122.47M97.07M86.16M79.20M67.64M65.32M
Gross Profit 41.88M41.71M32.05M47.74M160.88M88.27M102.81M206.62M205.20M122.47M97.07M86.16M79.20M67.64M65.32M
Operating items
Research & Development 11.55M15.12M16.84M18.74M23.19M40.46M57.45M94.86M142.21M136.76M174.11M164.52M163.52M131.48M106.74M
Selling, General & Administrative 5.04M5.30M6.18M10.02M13.54M16.97M20.75M23.44M26.25M27.36M32.54M45.48M52.89M57.85M43.93M
Operating Expenses 16.58M20.42M23.02M28.76M36.73M57.43M78.20M118.30M168.46M164.11M206.65M210.00M216.41M189.33M150.67M
Operating Income 25.30M21.29M9.03M18.98M124.15M30.84M24.61M88.33M36.74M-41.64M-109.57M-123.84M-137.21M-121.69M-85.35M
EBIT 25.30M21.29M9.03M18.98M124.15M30.84M24.61M88.33M36.74M-41.64M-109.57M-123.84M-137.21M-121.69M-85.35M
Non-operating items
Interest & Investment Income 0.08M0.12M0.25M0.47M0.97M1.69M2.49M4.85M8.82M6.47M2.02M1.57M11.36M14.77M9.44M
Other Non Operating Income -0.69M-0.01M0.38M-0.17M0.35M0.03M-0.16M-0.06M0.15M-0.03M
Non Operating Income -1.99M0.11M0.60M0.28M1.31M1.72M2.33M4.79M8.82M6.62M1.99M1.66M6.21M3.90M1.80M
Net income details
EBT 22.22M21.40M9.63M19.27M125.45M32.56M26.95M93.12M45.56M-35.02M-107.58M-122.19M-131.00M-117.79M-83.55M
Tax Provisions -15.17M46.46M12.23M10.08M21.16M1.84M-8.49M-28.72M-0.45M2.82M-1.94M-1.77M
Profit After Tax 23.31M21.40M9.63M34.44M78.99M21.67M17.71M71.96M46.38M-36.17M-79.00M-121.75M-133.82M-116.05M-81.89M
Income from Continuing Operations 22.22M21.40M9.63M34.44M78.99M20.33M16.87M71.96M43.72M-26.53M-78.86M-121.74M-133.82M-115.85M-81.78M
Consolidated Net Income 22.22M21.40M9.63M34.44M78.99M20.33M16.87M71.96M43.72M-26.53M-78.86M-121.74M-133.82M-115.85M-81.78M
Income towards Parent Company 22.22M21.40M9.63M34.44M78.99M20.33M16.87M71.96M43.72M-26.53M-78.86M-121.74M-133.82M-115.85M-81.78M
Preferred Dividend Payments 16.29M14.66M13.67M
Net Income towards Common Stockholders 1.56M1.37M-6.57M34.44M78.99M20.33M16.87M71.96M43.72M-26.53M-78.86M-121.74M-133.82M-115.85M-81.78M
Additional items
EPS (Basic) 0.00M0.00M-0.00M0.00M0.00M0.00M0.00M0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) 0.00M0.00M-0.00M0.00M0.00M0.00M0.00M0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 17.91M18.58M18.71M19.04M19.09M19.38M19.68M20.07M20.21M20.72M21.06M21.19M21.38M
Shares Outstanding (Diluted Average) 0.02M0.02M0.02M0.02M0.02M0.02M
EBITDA 25.30M21.29M9.03M18.98M124.15M30.84M24.61M88.33M36.74M-41.64M-109.57M-123.84M-137.21M-121.69M-85.35M
Tax Rate 37.04%37.57%37.40%22.73%4.04%24.25%26.70%0.37%1.64%2.12%